CNC — Centene Corp.

Centene Corporation (CNC) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Adjusted Diluted EPS: $3.37, exceeding expectations and leading to an increase in full-year guidance to greater than $3.40 (up from >$3.00).
• Total Revenue: $44.7 billion in premium and service revenue.
• Consolidated HBR: 87.3% for Q1, with Medicaid HBR at 93.1%, an improvement from the previous year.
• Medicaid Membership: 12.4 million, slightly down from year-end.
• Medicare Advantage HBR: 84.9%, better than forecasted.
• Marketplace Membership: 3.58 million, consistent with expectations.

2. Strategic Updates and Business Highlights

• Medicaid Business: Strong performance attributed to operational improvements and a lighter flu season. Initiatives to modernize processes and manage medical costs are yielding positive results.
• Medicare Segment: Both Medicare Advantage and PDP exceeded expectations, with a focus on aligning membership with Medicaid footprint and improving member retention.
• Marketplace: Adjusted strategies based on new data, with expectations for risk adjustment offsets for higher acuity Silver tier members.
• Leadership Changes: Dan Finke appointed as Group President for Medicaid and Commercial businesses; Michael Carson elevated to oversee Medicare PDP and Specialty businesses.
• Fraud, Waste, and Abuse Initiatives: Continued focus on addressing these issues, particularly in ABA, with advocacy for program reforms to enhance integrity.

3. Forward Guidance and Outlook

• Full-Year Guidance: Adjusted EPS guidance raised to >$3.40, with a composite rate yield expectation of approximately 4.5% for Medicaid.
• Marketplace Margin: Current guidance reflects a pretax margin of around 3%, not accounting for full potential risk adjustment offsets.
• Cash Flow: Strong operational cash flow of $4.4 billion, with a debt-to-cap ratio reduced to 43.2%.

4. Bad News, Challenges, or Points of Concern

• Declining Medicaid Membership: Expected to decrease by about 6% year-over-year.
• Elevated Medical Trends: Continued high trends in medical and pharmacy costs, particularly in specialty drugs, impacting profitability.
• Marketplace Utilization: Higher-than-expected utilization in Silver tier members could lead to increased HBR.
• Potential Rate Headwinds: Discussions around work requirements and their impact on acuity and rates could pose challenges in future negotiations with state partners.

5. Notable Q&A Insights

• Higher Acuity in Silver Tier: The shift in membership demographics due to the expiration of enhanced APTCs has led to a higher acuity cohort remaining in the Silver tier, which is expected to result in a risk adjustment receivable.
• Medicaid Rate Development: Conversations with states are constructive, with a focus on aligning rates with acuity data and managing costs effectively.
• Fraud Management: There is an ongoing dialogue with states regarding the impact of fraud initiatives on rates, with a willingness to explore program reforms that do not necessitate rate increases.
• Marketplace Dynamics: The company is optimistic about the potential for margin recovery in the Marketplace business, with insights from the Wakely data expected to refine forecasts.

Overall, Centene's Q1 2026 results reflect strong operational performance, particularly in Medicaid and Medicare segments, while also highlighting challenges in managing costs and membership dynamics in the Marketplace. The company remains focused on strategic initiatives to enhance profitability and program integrity moving forward.